A study of Acebrophylline (Ambroxol acephyllinate) for the treatment of bronchial diseases.

Trial Profile

A study of Acebrophylline (Ambroxol acephyllinate) for the treatment of bronchial diseases.

Planning
Phase of Trial: Phase I

Latest Information Update: 10 Mar 2016

At a glance

  • Drugs Acebrophylline (Primary)
  • Indications Bronchial disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Mar 2016 New trial record
    • 08 Mar 2016 According to a Hyundai Pharmaceutical media release, the company has submitted IND to SFDA. The trial is expected to begin in the end of 2014 and the product approval is expected in the middle of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top